Benzinga's Top #PreMarket Gainers

shares gained 29.41% to $49.99 in the pre-market trading session after the company reported upbeat quarterly results and raised its full-year revenue forecast. The company also received the FDA HDE approval for the Impella RP.

shares rose 7.66% to $22.90 in pre-market trading after the company reported better-than-expected earnings for the fourth quarter.

shares jumped 7.50% to $117.32 in pre-market trading after the company announced stronger-than-expected financial results for its fiscal 2015 first quarter. The company sold 74.5 million iPhones in the quarter.

gained 5.33% to $50.55 in pre-market trading after the company reported upbeat fourth-quarter results and unveiled spin-off plans for its

stake.

shares surged 3.03% to $136.50 in pre-market trading after the company posted better-than-expected fourth-quarter earnings.